Caverject Impulse (U.S. Pharmaceuticals)
Welcome to the PulseAid listing for the Caverject Impulse drug offered from U.S. Pharmaceuticals. This Genitourinary Arterial Vasodilation [PE],Prostaglandin Analog [EPC],Prostaglandin E1 Agonist [EPC],Prostaglandin Receptor Agonists [MoA],Prostaglandins [Chemical/Ingredient],Venous Vasodilation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | U.S. Pharmaceuticals |
| NON-PROPRIETARY NAME: | Alprostadil |
| SUBSTANCE NAME: | ALPROSTADIL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Genitourinary Arterial Vasodilation [PE],Prostaglandin Analog [EPC],Prostaglandin E1 Agonist [EPC],Prostaglandin Receptor Agonists [MoA],Prostaglandins [Chemical/Ingredient],Venous Vasodilation [PE] |
| ROUTE: | INTRACAVERNOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-05-04 |
| END MARKETING DATE: | 0000-00-00 |
Caverject Impulse HUMAN PRESCRIPTION DRUG Details:
| Item Description | Caverject Impulse from U.S. Pharmaceuticals |
| LABELER NAME: | U.S. Pharmaceuticals |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(ug/.5mL) |
| START MARKETING DATE: | 2014-05-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63539-121_0dcd3231-552e-4243-bbc9-b8ed733d3ff4 |
| PRODUCT NDC: | 63539-121 |
| APPLICATION NUMBER: | NDA021212 |
Other ALPROSTADIL Pharmaceutical Manufacturers / Labelers:
